PDE5i Archives - Well Referenced

Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction

This Swedish nationwide cohort study analyzed 43,145 men under 80 years old who experienced a first myocardial infarction (MI) between 2007 and 2013. Over an average follow-up of 3.3 years, 7.1% received treatment for erectile dysfunction (ED) with either phosphodiesterase-5 inhibitors (PDE5i) or alprostadil. Men treated for ED had a

June 26, 2025 No Comments

Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails

This systematic review, titled “Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails,” published in Sexual Medicine Reviews in 2019 (PMID: 30711478), evaluated the efficacy and safety of second-line oral combination therapies for erectile dysfunction (ED) in patients unresponsive to phosphodiesterase type 5

June 26, 2025 No Comments

Tag: PDE5i

Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction

Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails